Serglycin (SRGN) is a pro-tumorigenic PG expressed and secreted by a variety of aggressive tumor cells, including GBM [12,13], breast [14,15,16], multiple myeloma [17,18] and nasopharyngeal cancer cells [19]. The gene discussed is SRGN; the disease is nasopharyngeal carcinoma.